Jobs / United States / Abbvie INC
Specialist, Contract Management Pharmaceutical Development
Abbvie INC · 🇺🇸 Tianjin, Tianjin, CN
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 177 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 94 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Abbvie INC paid sponsored hires in similar roles2 certified filings for “ASSOCIATE DIRECTOR, HR DATA MANAGEMENT AND GOVERNANCE” (Database Architects) in TX: $153k–$187k, median $170k. Most were filed at wage level III (50%) — 3 lottery entries, ≈46% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Abbvie INC
The US Department of Labor certified 177 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 94 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Abbvie INC →
About the role
Purpose: Describe the primary goals, objectives or functions or outputs of this position. The Contract Management Specialist is responsible for the timely and appropriate execution of Confidentiality Disclosure Agreements (CDAs), Clinical Study Agreements (CSAs), associated Budgets, other site agreements and vendor agreements and issues on other legal, compliance, regulatory and policy matters (such as Insurance Policies, FMV, FCPA, etc.). With the minimum support from CMS manager and in partnership with Legal they ensure that issues and points of negotiation are settled rapidly in support of our new model to minimize or eliminate negotiation and our aspirational target of first pass acceptance of these documents. The overall aim is to keep CDAs, Contracts and Budgets off the clinical study critical path for all AbbVie studies (both Site Management & Monitoring and CRO conducted studies). The responsibility is Global – all countries except US and Japan. Responsibilities: List up to 10 main responsibilities for the job. Include information about the accountability and scope. • Serve as point person of site contracts for Legal, Finance, Site Management & Monitoring and Study Team. • Accountable for timely Preparation and Execution of CDAs, CSAs and Budgets, other site agreements and related vendor agreements, either directly or via local staff where a region is supported and language requires local help. Budgets should be in line with Country Fair market Value and actuals should be monitored. Deviations from Legally approved contract templates should be approved by Legal and should be in line with guidance provided by Legal. • Direct negotiation of CDAs, CSAs and Budgets and other site agreements with investigator sites using templates, guidance and Playbook from Legal where language is not a problem, or with the help of the Monitor where local language necessitates. Deviations from Legally approved contract templates should be approved by Legal and should be in line with guidance provided by Legal. Site visits may be conducted if necessary. • Liaising with Legal where Playbook doesn’t already address an issue and seeking Legal approval for deviations. • Setting, managing and communicating priorities on site level to local affiliate stakeholders, Legal, and Finance in alignment with Study Plans and priority for start up. • Contribute site-level input to the continual update of Playbooks and Templates in collaboration with Legal. • Tracking CDAs, CSAs and other agreements in appropriate system and collecting relevant metrics. • Gathering, managing and tracking site intelligence and communicating such to appropriate stakeholders in the Study Team, Legal, Finance, etc. • Ensuring that CDAs, CSAs and other agreements are off the critical path for study start up or study continued conduct where change orders are needed mid-study – meeting timeline commitments. Purpose: Describe the primary goals, objectives or functions or outputs of this position. The Contract Management Specialist is responsible for the timely and appropriate execution of Confidentiality Disclosure Agreements (CDAs), Clinical Study Agreements (CSAs), associated Budgets, other site agreements and vendor agreements and issues on other legal, compliance, regulatory and policy matters (such as Insurance Policies, FMV, FCPA, etc.). With the minimum support from CMS manager and in partnership with Legal they ensure that issues and points of negotiation are settled rapidly in support of our new model to minimize or eliminate negotiation and our aspirational target of first pass acceptance of these documents. The overall aim is to keep CDAs, Contracts and Budgets off the clinical study critical path for all AbbVie studies (both Site Management & Monitoring and CRO c